Page last updated: 2024-11-01

norfluoxetine and Smoking Cessation

norfluoxetine has been researched along with Smoking Cessation in 1 studies

norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation

Smoking Cessation: Discontinuing the habit of SMOKING.

Research Excerpts

ExcerptRelevanceReference
"Fluoxetine improves affect in clinical syndromes such as depression and premenstrual dysphoric disorder."9.11Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial. ( Borrelli, B; Cook, JW; Hitsman, B; Keuthen, NJ; Kristeller, J; McChargue, DE; Niaura, R; Spring, B, 2004)
"Fluoxetine improves affect in clinical syndromes such as depression and premenstrual dysphoric disorder."5.11Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial. ( Borrelli, B; Cook, JW; Hitsman, B; Keuthen, NJ; Kristeller, J; McChargue, DE; Niaura, R; Spring, B, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cook, JW1
Spring, B1
McChargue, DE1
Borrelli, B1
Hitsman, B1
Niaura, R1
Keuthen, NJ1
Kristeller, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00113737]0 participants Interventional1998-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for norfluoxetine and Smoking Cessation

ArticleYear
Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial.
    Psychopharmacology, 2004, Volume: 173, Issue:1-2

    Topics: Adult; Affect; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Combined Moda

2004